UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of bone and mineral research, ISSN 0884-0431, 10/2016, Volume 31, Issue 10, pp. 1845 - 1854
FAMILIAL TUMORAL CALCINOSIS | HYPEROSTOSIS‐HYPERPHOSPHATEMIA SYNDROME | FIBROBLAST GROWTH FACTOR 23 | HYPERPHOSPHATEMIA | HYPEROSTOSIS-HYPERPHOSPHATEMIA SYNDROME | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Calcinosis - genetics | Humans | Hyperostosis, Cortical, Congenital - therapy | Fibroblast Growth Factors - genetics | Male | Hyperostosis, Cortical, Congenital - pathology | Hyperphosphatemia - pathology | Hyperphosphatemia - blood | Hyperostosis - blood | N-Acetylgalactosaminyltransferases - genetics | Adult | Female | Hyperostosis - pathology | Hyperphosphatemia - therapy | Child | Hyperostosis - genetics | Hyperostosis - therapy | Calcinosis - blood | Hyperostosis, Cortical, Congenital - genetics | Hyperostosis, Cortical, Congenital - blood | Calcinosis - therapy | Glucuronidase - genetics | Adolescent | Hyperphosphatemia - genetics | Calcinosis - pathology | Cohort Studies | Care and treatment | Phosphorus imbalance | Genetic aspects | C-reactive protein | Gene mutations | Index Medicus | hyperostosis-hyperphosphatemia syndrome | Familial tumoral calcinosis | hyperphosphatemia | fibroblast growth factor 23
Journal Article
Kidney international, ISSN 0085-2538, 06/2011, Volume 79, Issue 12, pp. 1370 - 1378
phosphate | FGF23 | chronic kidney disease | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Kidneys | Urinary system involvement in other diseases. Miscellaneous | Nephropathies. Renovascular diseases. Renal failure | Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Predictive Value of Tests | Up-Regulation | Biomarkers - urine | Prospective Studies | United States | Humans | Middle Aged | Hyperparathyroidism, Secondary - physiopathology | Male | Parathyroid Hormone - blood | Renal Insufficiency, Chronic - complications | Hyperparathyroidism, Secondary - urine | Hyperphosphatemia - blood | Time Factors | Phosphates - urine | Phosphates - blood | Female | Hyperphosphatemia - urine | Renal Insufficiency, Chronic - diagnosis | Severity of Illness Index | Glomerular Filtration Rate | Phosphorus, Dietary - metabolism | Biomarkers - blood | Renal Insufficiency, Chronic - physiopathology | Renal Insufficiency, Chronic - blood | Hyperparathyroidism, Secondary - blood | Hyperparathyroidism, Secondary - diagnosis | Fibroblast Growth Factors - blood | Hyperphosphatemia - etiology | Aged | Hyperparathyroidism, Secondary - etiology | Hyperphosphatemia - physiopathology | Hyperphosphatemia - diagnosis | Renal Insufficiency, Chronic - urine | Index Medicus
Journal Article
Journal of cellular biochemistry, ISSN 0730-2312, 12/2017, Volume 118, Issue 12, pp. 4708 - 4715
AUTOPHAGY | HYPERPHOSPHATEMIA‐INDUCED VASCULAR CALCIFICATION | VASCULAR SMOOTH MUSCLE CELL | Nrf2‐ARE SIGNALING PATHWAY | Nrf2-ARE SIGNALING PATHWAY | HYPERPHOSPHATEMIA-INDUCED VASCULAR CALCIFICATION | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Kidney - blood supply | Kidney - pathology | Muscle, Smooth, Vascular - metabolism | Response Elements | Signal Transduction | Myocytes, Smooth Muscle - pathology | Hyperphosphatemia - metabolism | Rats | Vascular Calcification - prevention & control | Male | Vascular Calcification - pathology | Autophagy | Rats, Sprague-Dawley | Hyperphosphatemia - pathology | Vascular Calcification - metabolism | Kidney - metabolism | Muscle, Smooth, Vascular - pathology | Animals | Hyperphosphatemia - prevention & control | NF-E2-Related Factor 2 - metabolism | Myocytes, Smooth Muscle - metabolism | Prevention | Calcification | Smooth muscle | Bone morphogenetic proteins | Phosphorus imbalance | Transmission electron microscopes | Calcification (ectopic) | Cbfa-1 protein | Ion concentration | Kidneys | Bone morphogenetic protein 2 | Calcium | Genes | Phagosomes | Phosphorus | Activation | siRNA | Western blotting | Polymerase chain reaction | Antioxidants | Signal transduction | Biomedical materials | Hyperphosphatemia | Biocompatibility | Phagocytosis | Apoptosis | Index Medicus
Journal Article
Kidney international, ISSN 0085-2538, 11/2013, Volume 84, Issue 5, pp. 998 - 1008
dialysis | phosphate binders | mineral metabolism | hyperparathyroidism | hyperphosphatemia | mortality risk | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Multivariate Analysis | Prospective Studies | Hyperphosphatemia - mortality | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Hyperphosphatemia - blood | Renal Insufficiency, Chronic - therapy | Renal Dialysis - mortality | Time Factors | Aged, 80 and over | Cardiovascular Diseases - mortality | Phosphates - blood | Renal Insufficiency, Chronic - mortality | Female | Renal Insufficiency, Chronic - diagnosis | Chelating Agents - therapeutic use | Cardiovascular Diseases - diagnosis | Risk Factors | Proportional Hazards Models | Europe - epidemiology | Treatment Outcome | Biomarkers - blood | Chi-Square Distribution | Renal Insufficiency, Chronic - blood | Propensity Score | Renal Dialysis - adverse effects | Hyperphosphatemia - drug therapy | Aged | Hyperphosphatemia - diagnosis | Index Medicus | Medicin och hälsovetenskap
Journal Article
Kidney international, ISSN 0085-2538, 05/2018, Volume 93, Issue 5, pp. 1060 - 1072
phosphate binders | intestinal phosphate absorption | chronic kidney disease | hyperphosphatemia | dietary phosphate | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Risk Reduction Behavior | Humans | Risk Factors | Phosphorus, Dietary - adverse effects | Treatment Outcome | Biomarkers - blood | Phosphorus, Dietary - blood | Renal Insufficiency, Chronic - blood | Renal Insufficiency, Chronic - epidemiology | Hyperphosphatemia - blood | Renal Insufficiency, Chronic - therapy | Animals | Hyperphosphatemia - prevention & control | Hyperphosphatemia - epidemiology | Phosphates - blood | Recommended Dietary Allowances | Hyperphosphatemia - therapy | Chelating Agents - therapeutic use | Chelating Agents - adverse effects | Intervention | Phosphates | Additives | Kidneys | Working groups | Comorbidity | Hemodialysis | Toxicity | Mortality | Clinical trials | Homeostasis | Cardiovascular disease | Studies | Nutrition research | Diet | Phosphate | Hyperphosphatemia | Fast food | Physiology | Kidney diseases | Cardiovascular diseases | Index Medicus
Journal Article
Kidney international, ISSN 0085-2538, 09/2014, Volume 86, Issue 3, pp. 638 - 647
dialysis | phosphate binder | sevelamer | hyperphosphatemia | PA21 | adherence | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Nausea - chemically induced | Polyamines - adverse effects | Humans | Middle Aged | Induction Chemotherapy | Male | Polyamines - therapeutic use | Patient Dropouts | Renal Insufficiency, Chronic - complications | Diarrhea - chemically induced | Hyperphosphatemia - blood | Renal Insufficiency, Chronic - therapy | Adult | Female | Maintenance Chemotherapy | Sevelamer | Chelating Agents - therapeutic use | Chelating Agents - adverse effects | Constipation - chemically induced | Medication Adherence | Peritoneal Dialysis | Hyperphosphatemia - etiology | Phosphorus - blood | Ferric Compounds - therapeutic use | Hyperphosphatemia - drug therapy | Aged | Ferric Compounds - adverse effects | Index Medicus | Clinical Trial
Journal Article
Kidney international, ISSN 0085-2538, 02/2011, Volume 79, Issue 4, pp. 414 - 422
phosphate | gene transcription | hyperphosphatemia | osteopontin | vascular calcification | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Osteopontin - genetics | Nanoparticles - chemistry | Myocytes, Smooth Muscle - pathology | Hyperphosphatemia - metabolism | DNA Primers - genetics | Calcinosis - etiology | Base Sequence | Cell Differentiation | Calcinosis - metabolism | Myocytes, Smooth Muscle - drug effects | Myocytes, Smooth Muscle - metabolism | Calcium Phosphates - pharmacology | Osteogenesis - genetics | Hyperphosphatemia - complications | Bone Morphogenetic Protein 2 - genetics | Cell Line | Microscopy, Electron, Scanning | Nanoparticles - ultrastructure | Up-Regulation - drug effects | Animals | Hyperphosphatemia - genetics | Mice | Calcinosis - pathology | In Vitro Techniques | Calcium Phosphates - metabolism | Index Medicus
Journal Article